<DOC>
	<DOCNO>NCT00392509</DOCNO>
	<brief_summary>This study treat patient severe low leg ischemia vascular compromise pain rest . The goal compare treatment patient 's painful disorder inject cell calf leg test circulatory improvement . A treatment give random two group injection calf muscle ALD-301 ( specially process stem progenitor cell ) patient 's bone marrow , cell process routine minimally purifies cell . The study goal see ALD-301 cell effective generate new small blood vessel improve circulation affect leg .</brief_summary>
	<brief_title>ALD-301 Critical Limb Ischemia , Randomized Trial</brief_title>
	<detailed_description>Patients recruit critical limb ischemia pain rest . The study select patient treatment follow three month intervention . The treatment consist draw 2/3 cup bone marrow patient 's hip bone , process collect bone marrow follow : - The test group 's bone marrow process sort identify aldehyde dehydrogenase bright ALDH-br stem progenitor cell ( ALD-301 ) . These cell inject calf muscle patient clinic . - The control group amount bone marrow collect undergo simpler process isolate mononuclear cell whole bone marrow , remove red cell granulocytes cell preparation injection . The patient monitor adverse event related process determine safety approach . They also test interval study compare baseline value patient post-treatment value : 1. ankle-brachial index systolic blood pressure 2. transcutaneous oxygen measurement obtain skin treat leg 3. patient 's perception his/her quality life measure two different , validate questionnaire 4 . Measurements heel/foot ulcer , present , monitor degree healing occur 5. patient 's perception his/her level pain leg The patient receive call 6 month report additional life event follow study .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<criteria>Patients 18 year age great atherosclerotic vascular disease view readily amenable reconstructive surgery Rutherford Category 4 ischemia ( ischemic rest pain ) Rutherford Category 5 ischemia ( ulceration tissue necrosis ) judgment refer physician reasonable candidate revascularization option either percutaneous balloon angioplasty surgical revascularization . Objective evidence severe peripheral arterial disease include ankle brachial index ( ABI ) less 0.5 , , case patient vessel calcify thereby `` noncompressible '' vessel metatarsal pulse volume record ( PVR ) flat barely pulsatile diseased limb two consecutive examination perform least one week apart . Patients competent give inform consent . No active malignant disease could involve bone marrow , history treatment malignant disease could damage bone marrow . Before accepted study patient must screen human immunodeficiency virus , hepatitis B virus , hepatitis C virus , human transmissible spongiform encephalopathy , include CreutzfeldtJacob Disease , Treponema pallidum , negative standard infectious disease panel include CMV PCR test . Patients hemodynamically stable . Patients poorly control diabetes mellitus ( HbA1C &gt; 8 % ) Patients renal insufficiency ( creatinine &gt; 2.5 ) . Patients evidence infectious disease determine e. medical finding . Pregnant woman ( woman capable childbearing must negative pregnancy test ) . Patients cognitive impairment . Other comorbid disease would expect result less one year life expectancy Past malignancy history chemotherapy radiation affect bone marrow . History inflammatory progressively fibrotic condition : .e.g. , rheumatoid arthritis , systemic lupus erythematosis , vasculitic disorder , idiopathic pulmonary fibrosis , retroperitoneal fibrosis Infection evidence WBC count &gt; 15,000 and/or temperature &gt; 38 degree C. Large area cellulitis afflict limb opinion investigator would require institution antibiotic OR evidence osteomyelitis corroborate radiographic scintigraphic examination Cardiovascular condition : Exercise limit angina ( Canadian Cardiovascular Society Class 3 ( Appendix 7 ) ; Congestive heart failure ( New York Heart Association class 3 ( Appendix 5 ) ; Unstable angina ; Acute ST elevation myocardial infarction ( MI ) within 1month ; Transient ischemic attack stroke within 1 month ; Severe valvular disease Patients history organ transplant ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>critical limb ischemia</keyword>
	<keyword>cell therapy angiogenesis</keyword>
	<keyword>aldehyde dehydrogenase-bright cell</keyword>
	<keyword>peripheral artery disease</keyword>
	<keyword>peripheral vascular disease</keyword>
	<keyword>leg pain</keyword>
	<keyword>PVD</keyword>
	<keyword>PAD</keyword>
	<keyword>CLI</keyword>
	<keyword>amputation</keyword>
	<keyword>limb salvage</keyword>
</DOC>